Abstract: The present invention relates to compositions and methods for inhibiting protein aging. Accordingly, a composition is disclosed which comprises an agent or compound capable of inhibiting the formation of advanced glycosylation end products of target proteins by reacting with the carbonyl moiety of the early glycosylation product of such target proteins formed by their initial glycosylation. Suitable agents may contain an active nitrogen-containing group, such as a hydrazine group, and may further be at least partially derived from amino acids. Particular agents comprise aminoguanidine, .alpha.-hydrazinohistidine and lysine. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be treated.
Type:
Grant
Filed:
November 14, 1985
Date of Patent:
July 19, 1988
Assignee:
The Rockefeller University
Inventors:
Anthony Cerami, Peter C. Ulrich, Michael Brownlee
Abstract: The present invention provides a blended preparation for the separation especially of coal particles from the tailings which are contained in the fines produced in coal mining. The blended preparation is used instead of or in addition to the conventional froth oil. The blended preparation comprises froth oil, flocculating agent, emulsifying agent, water and optionally, anti-freeze. The use of the preparation results in faster separation and saving in flocculating agent.
Type:
Grant
Filed:
March 5, 1986
Date of Patent:
July 12, 1988
Assignee:
Carbo Fleet Chemical Co., Ltd.
Inventors:
Derek O'Neill, James A. Robson, Leonard K. Pugh
Abstract: There is disclosed an improved prosthesis coated, respectively, with an ionic surfactant, an antibiotic and/or antithrombiotic agent and treated with an immobilizing ionic exchange compound, to remove un-antibiotic bound ionic surfactant. The drug may be encapsulated within phospholipid vesicles which are bound to the prosthesis.
Type:
Grant
Filed:
April 11, 1986
Date of Patent:
June 7, 1988
Assignees:
University of Medicine and Dentistry of New Jersey, Rutgers University
Inventors:
Ralph S. Greco, Richard A. Harvey, Stanley Z. Trooskin, George Strauss
Abstract: The invention provides an electrolyte cell which is used for the electrodeposition of silver from a fixer medium (used as the electrolyte) which has previously been used and has to be re-used for developing photographic films, X-ray plates and the like processes wherein silver is extruded by the treatment process. While the silver electrodeposition is taking place, air is bubbled through the electrolyte to prevent copper sulfate and the additives in the electrolyte from settling out and aggregating which shortens the life of the fixer medium. The electric potential which is applied to the electrodes is such as to give a much smaller electrolyzing current i.e. up to 1 amp compared to the more usual electrolyzing currents of 10 amp or more.
Abstract: There is disclosed an improved prosthesis coated, respectively, with a cationic surfactant, an antibiotic compound and treated with an cationic exchange compound, to remove un-antibiotic bound cationic surfactant.
Type:
Grant
Filed:
July 23, 1984
Date of Patent:
April 26, 1988
Assignee:
University of Medicine & Dentistry of New Jersey
Inventors:
Ralph S. Greco, Richard Harvey, Stanley Z. Trooskin
Abstract: Imminent failure of a hose or other conduit is detected by a dye disposed between the conduit's outer and inner walls. The invention is especially applicable to automotive cooling systems.
Abstract: Ophthalmic compositions containing (-)-5-{(R)-1-Hydroxy- 2[(R)-1-methyl-3-phenylpropyl)amino]ethyl}salicylamide and a method of using them in the treatment of glaucoma are disclosed.
Abstract: 2-(Alkylthio, alkylsulfinyl or alkylsulfonyl)-4-[2-(anilinoalkylamino)-1-hydroxyalkyl]phenols and derivatives thereof, particularly useful as agents for the treatment of hypertension, are disclosed herein.
Abstract: 6-(Heterocyclic)hydroxymethylpenicillanic acids and compounds related thereto are prepared by reaction of a 6,6-dihalopenicillanic acid with a Grignard reagent and a heterocyclic aldehyde in an anhydrous aprotic solvent. The compounds possess useful antibacterial activity.
Type:
Grant
Filed:
May 9, 1979
Date of Patent:
December 8, 1981
Assignee:
Schering Corporation
Inventors:
Patricia L. Cavender, Ashit K. Ganguly, Viyyoor M. Girijavallabhan
Abstract: The present invention relates to topical compositions and methods of use utilizing compounds of the formula ##STR1## wherein X is oxygen or sulfur;W is a bridge group of the formulae ##STR2## wherein R is hydrogen alkyl of 1 to 7 carbon atoms, cycloalkyl of 4-8 carbon atoms, cycloalkenyl of 5-8 carbon atoms, polyfluoroalkyl of 1-4 carbon atoms, phenyl, benzyl or alkoxycarbonylmethyl; R.sub.1 is hydrogen or alkyl of 1-7 carbon atoms; m is 0-2; n is 1-4; with the proviso that m+n is 3-5; andA.sub.1, A.sub.2, A.sub.3, A.sub.4, B.sub.1, B.sub.2, B.sub.3, and B.sub.4 are independently selected from the group consisting of hydrogen, methyl, cyano, nitro, polyfluoroalkyl of 1-3 carbon atoms, chloro, bromo, fluoro and alkylthio, with the proviso that 2-5 of there are hydrogen of which at least one of A.sub.1, A.sub.2, A.sub.3 and A.sub.4 and at least one of B.sub.1, B.sub.2, B.sub.3 and B.sub.4 is hydrogen.
Abstract: .beta.-Lactams having a substituted hydroxymethylene group at the position .alpha. to the lactam carbonyl group are prepared by reaction of an .alpha.-halo-.beta.-lactam with zinc or zinc amalgam in an anhydrous aprotic medium to produce an intermediate which in situ reacts with an appropriate aldehyde or ketone.Also described are novel penicillins and cephalosporins having useful antibacterial activity.
Type:
Grant
Filed:
October 4, 1979
Date of Patent:
August 11, 1981
Assignee:
Schering Corporation
Inventors:
Ashit K. Ganguly, Viyyoor M. Girijavallabhan, Patricia Cavender, Olga Sarre, Stuart W. McCombie
Abstract: .beta.-Lactams having a substituted hydroxymethylene group at the position .alpha. to the lactam carbonyl group are prepared by reaction of an .alpha.-halo-.beta.-lactam with zinc or zinc amalgam in an anhydrous aprotic medium to produce an intermediate which in situ reacts with an appropriate aldehyde or ketone.Also described are noval penicillins and cephalosporins having useful antibacterial activity.
Type:
Grant
Filed:
June 2, 1978
Date of Patent:
June 9, 1981
Assignee:
Schering Corporation
Inventors:
Ashit K. Ganguly, Viyyoor M. Girijavallabhan, Patricia Cavender, Olga Sarre, Stuart W. McCombie
Abstract: Omega-[4-(polyfluoro-2-hydroxy-2-propyl)-2,3,6-substituted-phenoxy and phenylthio]alkanoic acids and compounds related thereto having antihypertensive activity are preparable by reaction of the appropriate 2,3,6-substituted-4-(polyfluoro-2-hydroxy-2-propyl)phenol or thiophenol with an alkyl ester of a bromoalkanoic acid, followed by hydrolysis to the free acid.
Abstract: N-substituted-4-(polyfluoro-2-hydroxy-2-propyl)anilines and compounds related thereto, useful as antihypertensive agents, are prepared by reaction of an N-substituted aniline with a polyfluoroacetone.
Abstract: An ophthalmic gel having an improved intensity and duration of the biological response is provided by utilizing a polyvinyl alcohol-sodium borate gel buffered to a pH of 6.5-8.5.
Type:
Grant
Filed:
November 22, 1978
Date of Patent:
March 10, 1981
Assignee:
Schering Corporation
Inventors:
Sukhbir S. Chrai, Santosh Gupta, Michael J. Hensley
Abstract: Reaction of 6- or 7-diazo-.beta.-lactams with allylic halides in the presence of a catalytic amount of metallic copper or a copper salt affords 6- or 7-carbon-substituted-.beta.-lactams with the desired stereochemical configuration at the 6- or 7-position. Subsequent reduction with a trialkyl stannane affords useful intermediates for further syntheses affording 6- or 7-carbon-substituted-.beta.-lactams.The present invention relates to a process for the production of 6- or 7-carbon-substituted-.beta.-lactams having the desired stereochemical configuration at the 6- or 7-position. More particularly, this invention provides a process for the preparation of a .beta.-lactam of the formula ##STR1## wherein R.sub.1 is cyano or COOR.sub.2 wherein R.sub.2 is a readily removable ester-forming moiety, hydrogen or an alkali-metal cation;R.sub.3 and R.sub.4 are independently hydrogen, lower alkyl, aryl or aralkyl;Z is a group of the formula ##STR2## wherein R.sub.
Abstract: Disclosed are novel substituted 4'-polyhaloisopropylsulfonanilides which are anti-hypertensive agents useful in the treatment of mammalian hypertension. Additionally, the compounds exhibit herbicidal and fungicidal activity. The compounds are prepared by contacting a 4-polyhaloisopropylaniline with the appropriate substituted-sulfonyl chloride.